Management of Pulmonary Arterial Hypertension

PURPOSE OF REVIEW: This review focuses on the therapeutic management and individualized approach to Group 1 pulmonary arterial hypertension (PAH), utilizing Food and Drug Administration-approved PAH-specific therapies and various interventional and surgical options for PAH. RECENT FINDINGS: The para...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Curr Cardiovasc Risk Rep
Asıl Yazarlar: Mayeux, Jennalyn D., Pan, Irene Z., Dechand, John, Jacobs, Joshua A., Jones, Tara L., McKellar, Stephen H., Beck, Emily, Hatton, Nathan D., Ryan, John J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer US 2020
Konular:
Secondary Prevention and Intervention (D. Steinberg)
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7671829/
https://ncbi.nlm.nih.gov/pubmed/33224405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12170-020-00663-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller